Remove Definition Remove Drug Development Remove Health Policy
article thumbnail

Healthcare AI investment will shift to these 5 areas in the next 2 years: survey

Henry Kotula

At life sciences companies, AI is primarily deployed during the drug development process to improve record-keeping and the application process, the survey found. The Consumer Technology Association (CTA) created a working group two years ago to develop some standardization on definitions and characteristics of healthcare AI.